Clinical trials: Floppy Iris Syndrome, active
Benign Prostatic Hyperplasia, Tamsulosin
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
Inhibition of alpha-1 adrenergic receptors by drugs such as tamsulosin and silodosin, which are prescribed for the treatment of benign prostatic hyperplasia, can lead to intraoperative floppy iris syndrome (IFIS) during cataract…
- Conditions
- Benign Prostatic Hyperplasia, Tamsulosin, Silodosin, Intraoperative Floppy Iris Syndrome
- Trial name
- NCT07743034
- Testing
- tamsulosin 0.4mg, Silodosin 8 mg
- Volunteers
- 40 people
- Sponsor
- Mohsen Pourazizi